NL-OMON53491
Recruiting
Not Applicable
Postponing cognitive decline and preventing early unemployment in patients with multiple sclerosis - strengthening the brain and mind (part of the Don't be late! study) - Don't be late! WP 2 and 3
Amsterdam UMC0 sites270 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- MS
- Sponsor
- Amsterdam UMC
- Enrollment
- 270
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Confirmed MS diagnosis according to McDonald 2017 criteria
- •\- Age between 18 and 67
- •\- No changes in disease modifying therapy prior to inclusion (i.e. no changes
- •in last 3 months)
- •\- No current relapse or steroid treatment in the six weeks prior to the study
- •\- Sublinical cognitive impairment
Exclusion Criteria
- •\- Patients with neurological (other than MS) and psychiatric disorders
- •\- A current or history of drug or alcohol abuse
- •\- Being unable to speak or read in Dutch
- •\- Currently on sick leave and working for less than 12 hours for a period of 3
- •months or longer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Towards Onset Prevention of COGnitive decline in adults with Down syndrome (the TOP-COG study) - The TOP-COG studyAlzheimer's disease Down syndromeMedDRA version: 14.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.0 Level: LLT Classification code 10013616 Term: Down's syndrome System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2011-001564-21-GBHS Greater Glasgow and Clyde70
Completed
Not Applicable
Towards Onset Prevention of COGnition decline in adults with Down syndrome (the TOP-COG study)Dementia in people with Down syndromeMental and Behavioural DisordersDementia in other diseases classified elsewhereISRCTN67338640HS Greater Glasgow and Clyde (UK)60
Recruiting
Not Applicable
Development of a novel method to prevent cognitive decline using a "healing smart space" that stimulates the five sensesMild cognitive impairment, behavior and psychological symptoms of dementia, stressJPRN-UMIN000046310Osaka Center for Cancer and Cardiovascular Disease Prevention60
Active, not recruiting
Phase 1
Preventing Cognitive Decline and Dementia from Cerebral Small Vessel Diseaseacunar (small vessel) ischaemic strokeMedDRA version: 19.0 Level: LLT Classification code 10023987 Term: Late effects of cerebrovascular disease System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: LLT Classification code 10042244 Term: Stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10068644 Term: Brain stem stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10071043 Term: Basal ganglia stroke System Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001953-33-GBniversity of Edinburgh60
Not yet recruiting
Phase 3
The feasibility of REducing Cognitive decline and dementiA by Lowering bLood pressure Pilot (RECALL Pilot)dementiamild cognitive impairmentcardiovascular diseasehypertensionNeurological - DementiasCardiovascular - HypertensionACTRN12623000555651The George Institute for Global Health300